Literature DB >> 6124326

Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.

R Erbel, J Meyer, H Lambertz, P Schweizer, W Voelker, W Krebs, G Braun, S Effert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6124326     DOI： 10.1161/01.cir.66.2.361

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.

Authors:  P J Currie; M J Kelly; K Middlebrook; J Federman; E Sainsbury; J Ashley; A Pitt
Journal:  Br Heart J       Date:  1984-05

2.  Acute haemodynamic effects of oral prenalterol in severe heart failure.

Authors:  M C Petch; C Wisbey; O Ormerod; C Scott; R M Goodfellow
Journal:  Br Heart J       Date:  1984-07

3.  Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.

Authors:  S Rasmussen; P F Høilund-Carlsen; B Hesse; O J Hartling; J Fabricius; H Dige-Petersen; J Giese
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure.

Authors:  D N Sharpe; R Coxon
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Pharmacology and inotropic potential of forskolin in the human heart.

Authors:  M R Bristow; R Ginsburg; A Strosberg; W Montgomery; W Minobe
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

6.  Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.

Authors:  D R Glover; C G Wathen; R G Murray; M C Petch; A L Muir; W A Littler
Journal:  Br Heart J       Date:  1985-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.